Symbicort vs. Ventolin
See how Symbicort and Ventolin compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Symbicort is a daily maintenance inhaler combining a steroid and long-acting bronchodilator, while Ventolin is a fast-acting rescue inhaler for sudden symptoms.
Symbicort carries a boxed warning about LABA-related death risk and is never used alone for quick relief, so many patients also keep a rescue inhaler like Ventolin on hand.
Ventolin costs far less per month than Symbicort but only relieves symptoms as they happen and does not treat the underlying airway inflammation.
Symbicort vs. Ventolin Drug Summary
Symbicort
Symbicort is a combination inhaler containing budesonide, an inhaled corticosteroid, and formoterol, a long-acting beta2-agonist. It is used for daily maintenance treatment of asthma in people 6 and older and for COPD, taken as two inhalations twice a day. It is not meant to relieve a sudden asthma attack.
Ventolin
Ventolin contains albuterol, a short-acting beta2-agonist that works within minutes to open the airways. It is used to treat or prevent sudden bronchospasm and exercise-induced symptoms in people 4 and older, taken as needed rather than on a schedule. It is a rescue inhaler, not a daily controller medication.
Symbicort vs. Ventolin Side Effects
Symbicort
Ventolin
Symbicort vs. Ventolin Dosage
Symbicort
Ventolin
| STAGE | DOSE | WHEN |
| Starting dose | 2 inh 80/4.5mcg BID | At the start |
| Maximum dose | 2 inh 160/4.5mcg BID | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 2 inh every 4-6 hrs | At the start |
| Maximum dose | 2 inh before exercise | If needed |
| Dose changes | 2 increases | As tolerated |
Symbicort
| STAGE | DOSE | WHEN |
| Starting dose | 2 inh 80/4.5mcg BID | At the start |
| Maximum dose | 2 inh 160/4.5mcg BID | If needed |
| Dose changes | 1 increase | As tolerated |
Ventolin
| STAGE | DOSE | WHEN |
| Starting dose | 2 inh every 4-6 hrs | At the start |
| Maximum dose | 2 inh before exercise | If needed |
| Dose changes | 2 increases | As tolerated |
Symbicort vs. Ventolin Indications
Symbicort
Symbicort is FDA-approved as a daily maintenance treatment for asthma in patients 6 and older and for COPD, including chronic bronchitis and emphysema. It combines an inhaled steroid with a long-acting bronchodilator to reduce inflammation and keep airways open over time. It is not approved to stop an asthma attack that has already started.
Maintenance therapy for asthma (age 6+)
Maintenance therapy for COPD
Reduces asthma and COPD exacerbations
Not approved for acute bronchospasm relief
Ventolin
Ventolin is FDA-approved to treat or prevent sudden bronchospasm in patients 4 and older with reversible airway disease. It also prevents exercise-induced bronchospasm when used shortly before activity. It works quickly but only for a few hours, so it does not replace a daily controller medication.
Treats acute bronchospasm (age 4+)
Prevents exercise-induced bronchospasm
Used as needed, not on a fixed schedule
Not approved for children under 4
Symbicort vs. Ventolin Pros and Cons
Symbicort
Symbicort combines a corticosteroid and a long-acting bronchodilator in one inhaler, making it well suited for long-term control of asthma and COPD. Because it carries a boxed warning about LABA-related risk, it is prescribed alongside, not instead of, a rescue inhaler. Coverage varies by plan, and the brand-name list price is notably higher than a generic rescue inhaler.
Pros
FDA-approved for both asthma and COPD
Combines steroid and long-acting bronchodilator
Approved for children as young as 6
Reduces frequency of exacerbations with regular use
Cons
Not for relief of a sudden asthma attack
Boxed warning for LABA-related death risk
Requires twice-daily dosing even when symptom-free
Higher monthly cost, roughly $300 to $500 without insurance
Ventolin
Ventolin acts within minutes to relieve sudden asthma or COPD-related bronchospasm, making it the standard rescue option for flare-ups and exercise-induced symptoms. It does not address the airway inflammation that drives ongoing asthma, so it is typically paired with a maintenance medication like Symbicort. Generic albuterol HFA inhalers are widely available and inexpensive.
Pros
Works within minutes to relieve acute symptoms
Also prevents exercise-induced bronchospasm
Approved for children as young as 4
Generic versions cost roughly $28 to $45 per inhaler
Cons
Does not treat underlying airway inflammation
Not intended for regular daily maintenance use
Overuse has been linked to fatalities per FDA warning
Can raise heart rate and affect blood pressure
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.